Company profile
Labcorp Holdings Inc.
NYSE: LH · Healthcare · Medical - Diagnostics & Research
#33 of 1,422 Healthcare companies by revenue52nd-percentile growth
EA Score
84B+FH 81DQ 97GM 57SS 98
v0.1 · 65/100 weight · provisional
↑ workforce scale, disclosure history · ↓ 3-yr revenue growth, revenue growth (YoY)
Methodology →Revenue TTM
$14.1B
Rev growth YoY (TTM)
+7.3%
Net income (FY)
$876.5M
Employees
71,000
as of 2026-08-05
Market cap
$25.6B
as of 2026-08-05
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$14.0B$14.0B2025
Net income$876.5M$876.5M2025
Operating income$1.4B$1.4B2025
Total assets$18.4B$18.4B2025
Liabilities$9.8B$9.8B2025
Equity$8.6B$8.6B2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY21
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
LabCorp Diagnostics100%
By geography
Not disclosed.
The read
What is Labcorp Holdings Inc.’s revenue?
Labcorp Holdings Inc. booked $14.0B in FY2025 revenue, growing 7.2% year over year — about the middle of the pack among Healthcare companies we track, at a 6.3% net margin.
Peers · Healthcare
IQVIA Holdings Inc.79B+Regeneron Pharmaceuticals, Inc.85AViatris Inc.63CDaVita Inc.77B+Henry Schein, Inc.77B+BrightSpring Health Services, Inc. Common Stock69BKey facts
CEOAdam H. Schechter
SectorHealthcare
IndustryMedical - Diagnostics & Research
HeadquartersBurlington, NC
ExchangeNYSE: LH
Employees71,000
IPO date1990-03-29
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.